A recent study indicates that patients who discontinue popular GLP-1 drugs like semaglutide or tirzepatide can put back on lost weight much more quickly than those who halt conventional diet and exercise plans.
Research printed in a leading medical journal points out that while obese individuals can lose substantial amounts of their total mass while undergoing treatment, the mass returns at an estimated rate of 0.8 kg per month once they quit.
"Users purchasing such treatments need to be cognizant of the potential of quick weight regain when the medication is stopped," warns lead investigator Dr. Susan Jebb.
This pace of recovery means a return to original mass in about 18 months.
Analyzing Treatments
The research, which looked at dozens of trials involving over 9,000 of participants, compared the outcomes of these new drugs with other pills.
The team emphasize that individuals who lose weight through dieting typically have a more gradual weight regain—perhaps 100 grams monthly—once they finish.
Understanding the Quick Regain
Nutrition scientists propose the mode of action of the drugs explains the heightened regain.
The injections copy a natural hormone called GLP-1, which controls feelings of fullness.
"Sustained high doses of GLP-1 levels several times higher than normal might result in the system to generate a reduced amount of its endogenous hormone, and could reduce sensitivity to its actions," explained Dr. Adam Collins, a nutrition specialist.
"Discontinuation of this GLP-1 'fix' results in appetite is unsuppressed, making binge eating a significant risk."
An Ongoing Disease?
Medical guidelines advise the injections for individuals with weight-linked health risks, accompanied by prescribed lifestyle changes.
Many experts argue that, considering the likelihood of relapse, the therapy should be considered life-long.
This perspective is supported by pharmaceutical companies, who note that the findings "emphasize the persistent nature of excess weight," comparing it to managing diseases like diabetes.
User Accounts
Users who have stopped the medication explain a intense resurgence of hunger.
"It felt as if something flipping and you're instantly ravenous," recalled an individual.
This challenge is worsened if individuals have not established permanent lifestyle or habit modifications during therapy.
Significant Adoption
Recent estimates indicate that a significant number of people in the UK have used these injections in the past year, with desire being substantial.
- Use is greater among women than males.
- The middle-aged demographic shows the greatest level of interest.
- Many access the drugs through private prescriptions rather than the NHS.
In conclusion, experts stress that while these medications are effective tools for shedding pounds, they are not a magic cure and maintained weight loss likely depends on combined behavioural support.
